1. Bartlett J.G., Dowell S.F., Mandell L.A., et al. Practice guidelines for the management of comm unity-acquired pneumonia in adults. Clin. Infect. Dis. 2000; 31: 347-382.
2. Niedermann M.S., Mandell L.A., Anzueto A. et al. Guidelines for the management of community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy and prevention. Am. J. Respir. Crit. Care Med. 2001; 163: 1730-1754.
3. Fine M.J., Smith M.A., Carson C.A. et al. Prognosis and outcome of patients with community-acquired pneumonia. A metaanalysis. J.A.M.A. 1996; 275: 134-141.
4. Внебольничная пневмония у взрослых: практические рекомендации по диагностике, лечению и профилактике. М.; 2003.
5. Battleman D.S., Callahan М., Thaler Н.Т. Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia. Arch. Intern. Med. 2002; 162: 682-688.
6. Gleason P.P., Meehan T.P., Fine M.J. et al. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch. Intern. Med. 1999; 159: 2562-2572.
7. Dean N.C., Silver M.P., Bateman K.A. et al. Decreased mortality after implementation of a treatment guideline for communityacquired pneumonia. Am. J. Med. 2001; 110: 451-457.
8. Grant W. W., Gregory S.J., Richard G.W. The impact of blood cultures on antibiotic therapy in pneumococcal pneumonia. Chest 1999; 116: 1278-1281.
9. Santiago E., Matthias S., Norbert G. et al. Applying sputum as a diagnostic tool in pneumonia. Chest 2002; 121: 1486-1492.
10. Ноников B.E. Внебольничные пневмонии: эмпирическая антибактериальная терапия. Рос. мед. журн. 2003; 11 (22): 1268-1272.
11. BTS. Guidelines for the management of com m unity-acquired pneumonia in adults. Thorax 2001; 56 (suppl. 4): 1-64.
12. Mandell L.A., Marrie T.J., Grossman R.F. et al. Canadian guidelines for the initial management of community-acquired pneumonia: An evidence-based update by the Canadian Infectious Diseases Society and Canadian Thoracic Society. Clin. Infect. Dis. 2000; 31: 383.
13. Guidelines for management of adult community-acquired lower respiratory tract infections. Eur. Respir. J. 1998; 11: 986 -991 .
14. David C.R. Overview of recent guidelines for the management of community-acquired pneumonia JC O M 2002; 9: 381 -389 .
15. Синопальников А.Я. Современный анализ рекомендаций по ведению больных внебольничной пневмонией: критический анализ. Клин, микробиол. и антимикроб, химиотер. 2003; 5 (3): 24-28.
16. Назаренко Г.И., Полубенцева Е.И. Управление качеством медицинской помощи. М.: Медицина; 2000.
17. David С. R. Quality indicators for the management of pneumonia in vulnerable elders. Ann. intern. Med, 2001; 135 (8 ): 736-743.
18. 7Д G.S., Meehan T.P., Fine M.J. et al. Which strategies facilitate improvement in quality of care for elderly hospitalized pneumonia patients? J. Commis. J. Quality Safety 2004; 30 (1): 25-35.
19. Meehan T.P., Fine M.J., Krumholz H.M. et al. Quality of care, process, and outcomes in elderly patients with pneumonia. J.A.M.A. 1997; 278: 2080-2084.
20. Pearson S.D., Goulart-Fisher D., Lee Т.Н. Critical pathway as a strategy for improving care: problems and potential. Ann. Intern. Med. 1995; 123: 941-948.
21. Marrie T.J., Lau C.Y., Wheller S.L. et al. A controlled trial of critical pathway for treatment of community-acquired pneumonia. J.A.M.A. 2000; 283 (6 ): 749 -754 .
22. Read R.C. Evidence-based medicine: empiric antibiotic therapy in community-acquired pneumonia. J. Infect. 1999; 39 (3): 171-178.
23. Cuastro-Guardiola F., IPiejo-Rodrigues A.L., Soler-Sim on A. et al. Efficacy and safety of oral and early-switch therapy of community-acquired pneumonia: a randomised controlled trial. Am. J. Med. 2001; 111: 367-374.
24. Ramirez J.A., Vargas S., Ritter G.W. et al. Early switch from intravenous to oral antibiotics and early hospital discharge: a prospective observational study of 2 0 0 consecutive patients with community-acquired pneumonia. Arch. Intern. Med. 1999; 159: 2449-2454.
25. Смоленое И.В. Роль неантибактериальных лекарственных средств в лечении пневмонии. Клин, микробиол. и антимикроб. химиотер. 2003; 5 (3): 18-23.